These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16272649)

  • 21. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.
    Coen G; Mazzaferro S; Bonucci E; Ballanti P; Massimetti C; Donato G; Landi A; Smacchi A; Della Rocca C; Cinotti GA
    Miner Electrolyte Metab; 1986; 12(5-6):375-82. PubMed ID: 3492662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of pulse therapy using 1 alpha(OH)D on secondary hyperparathyroidism in patients on maintenance hemodialysis].
    Yoshida K; Hirayama A; Tanaka N; Yasukawa M; Saka M; Kaneko Y; Maruyama Y; Motomiya Y; Ozono S; Hirao Y
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1117-23. PubMed ID: 2287104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary hyperparathyroidism in chronic kidney disease: focus on clinical consequences and vitamin D therapies.
    Hudson JQ
    Ann Pharmacother; 2006 Sep; 40(9):1584-93. PubMed ID: 16912241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total parathyroidectomy and renal function in patients with chronic renal failure.
    Chan YL; Posen S; Savdie E; Caterson RJ; Mahony JF
    Miner Electrolyte Metab; 1983; 9(2):57-61. PubMed ID: 6687751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary hyperparathyroidism: pathophysiology and treatment.
    Saliba W; El-Haddad B
    J Am Board Fam Med; 2009; 22(5):574-81. PubMed ID: 19734404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
    Wolf M; Thadhani R
    Semin Dial; 2005; 18(4):302-6. PubMed ID: 16076353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Attempt at evaluation of alfacalcidol administered by an oral pulsatile method to chronically dialysed patients with advanced secondary hyperparathyroidism].
    Bunio A; Kwieciński R
    Wiad Lek; 1994 May; 47(9-10):342-5. PubMed ID: 7817591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised clinical study of alfacalcidol and paricalcitol.
    Hansen D
    Dan Med J; 2012 Feb; 59(2):B4400. PubMed ID: 22293059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D receptor ligand therapy in chronic kidney disease.
    Gonzalez E
    Clin Nephrol; 2008 Oct; 70(4):271-83. PubMed ID: 18826852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated vitamin D sterols in kidney disease.
    Thadhani R
    Lancet; 2008 Feb; 371(9612):542-4. PubMed ID: 18280316
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of vitamin D metabolites and analogues on renal function.
    Naik RB; Cundy T; Robinson BH; Russell RG; Kanis JA
    Nephron; 1981; 28(1):17-25. PubMed ID: 6894966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin-D analogues and renal function.
    Lancet; 1978 Dec; 2(8102):1259-60. PubMed ID: 82768
    [No Abstract]   [Full Text] [Related]  

  • 34. [The trend in the development of the active vitamin D3 and its analogues].
    Miwa N; Akiba T
    Nihon Rinsho; 2004 May; 62 Suppl 5():364-7. PubMed ID: 15197946
    [No Abstract]   [Full Text] [Related]  

  • 35. Impairment of renal function in patients on 1alpha-hydroxycholecalciferol.
    Winterborn MH; Mace PJ; Heath DA; White RH
    Lancet; 1978 Jul; 2(8081):150-1. PubMed ID: 78344
    [No Abstract]   [Full Text] [Related]  

  • 36. Vitamin-D analogues and renal function.
    Compston JE; Horton LW; Laker MF
    Lancet; 1979 Feb; 1(8112):386. PubMed ID: 85037
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal function and 1 alpha-hydroxyvitamin D3 in rabbits with normal renal function and renal insufficiency.
    Tvedegaard E
    Scand J Urol Nephrol; 1983; 17(3):373-6. PubMed ID: 6648385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin-D analogues and renal function.
    Christiansen C; Christensen MS; Hartnack B; Melsen F; Transbøl I; Rødbro P
    Lancet; 1979 Jan; 1(8106):50-1. PubMed ID: 83502
    [No Abstract]   [Full Text] [Related]  

  • 39. No effect of low-dose 1 alpha-hydroxycholecalciferol treatment on the renal function deterioration rate in long-term uraemic rabbits.
    Tvedegaard E; Ladefoged O
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):385-90. PubMed ID: 6810651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin-D analogues and renal function.
    Farrington K; VArghese Z; Moorhead JF
    Lancet; 1978 Oct; 2(8096):941. PubMed ID: 81952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.